Junior Responsible Manager Delegate for Clinical Trial Materials at Eli Lilly and Company

Istanbul, Istanbul, Turkiye

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • University degree in Pharmacy from Türkiye
  • Minimum 2 years’ experience in quality assurance applied to the pharmaceutical industry
  • Working knowledge of GCP regulations and quality system implementation, with ability to interpret and apply them for QA responsibilities
  • Fluent in English (conversational, writing, and reading)
  • Knowledge and mastery of basic computing tools (Microsoft Office)
  • Good interpersonal relations
  • Ability to train working groups
  • Good analytical skills and attention to details
  • High initiative, learning agility, and a flexible, positive attitude
  • High degree of accuracy and attentive to details

Responsibilities

  • Act as delegated Responsible Manager to perform quality checks for the release of Clinical Trial Products upon arrival to Türkiye
  • Release clinical trial product shipments that meet all quality specifications and local regulations as a delegated Responsible Manager
  • Ensure compliance with local Good Clinical Practice (GCP) Quality System and applicable Türkiye MOH regulations
  • Support inspection readiness activities for MOH inspections
  • Assure that deviations, change management processes, root cause investigations, and corrective/preventive actions are effectively managed, documented, escalated, and completed in a timely manner
  • Monitor compliance with the external party responsible for storage and distribution of Clinical Trial Materials
  • Assist on training programs to external vendors which might have impact on Clinical Trial Material operations
  • Review returned products, ensure potential quality issues or failures are reported appropriately, and coordinate if new provisions apply
  • Support Quality Manager on reviewing/updating Quality Agreements related to Clinical Trial Products
  • Act as a point of contact for quality release of clinical trial materials in Türkiye affiliate
  • Provide appropriate escalation of issues to clinical teams and affiliate Responsible Manager
  • Understand performance metrics related to CT materials and identify areas for improvement and simplification
  • Understand SOPs and processes for CT materials

Skills

GCP
Quality Assurance
Pharmaceutical Quality
Regulatory Compliance
Deviation Management
Change Management
Root Cause Analysis
CAPA
Microsoft Office
English Fluency

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI